3P Biopharmaceuticals

Noain, Spain Founded: 2006 • Age: 20 yrs Acquired By Keensight Capital
CDMO specializing in biologics, biosimilars and cell therapy products
Request Access

About 3P Biopharmaceuticals

3P Biopharmaceuticals is a company based in Noain (Spain) founded in 2006 was acquired by Keensight Capital in July 2019.. 3P Biopharmaceuticals offers products and services including Proteins Manufacturing, Viral Vectors, Plasmid DNA, Cell Therapies, and Aseptic Fill and Finish. 3P Biopharmaceuticals operates in a competitive market with competitors including KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.

  • Headquarter Noain, Spain
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Keensight Capital

    (Jul 23, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of 3P Biopharmaceuticals

3P Biopharmaceuticals offers a comprehensive portfolio of products and services, including Proteins Manufacturing, Viral Vectors, Plasmid DNA, Cell Therapies, and Aseptic Fill and Finish. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Services for developing and manufacturing microbial and mammalian proteins.

Manufacturing of AAV and adenovirus vectors for therapeutic applications.

Production of plasmid DNA for research and clinical use.

Development and manufacturing services for cell-based treatments.

Sterile filling and finishing processes for biologics.

Quality control testing for biologics manufacturing processes.

Funding Insights of 3P Biopharmaceuticals

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in 3P Biopharmaceuticals

3P Biopharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Keensight Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Keensight Capital is recognized as a European Growth Buyout investor.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by 3P Biopharmaceuticals

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - 3P Biopharmaceuticals

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

3P Biopharmaceuticals Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of 3P Biopharmaceuticals

3P Biopharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of protein formulation, process & cell line development, and cGMP services
domain founded_year HQ Location
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
domain founded_year HQ Location
Integrated biologics development and manufacturing are provided as a CDMO.
domain founded_year HQ Location
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
domain founded_year HQ Location
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
domain founded_year HQ Location
Precision fermentation services for biopharma and food are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on 3P Biopharmaceuticals

Frequently Asked Questions about 3P Biopharmaceuticals

When was 3P Biopharmaceuticals founded?

3P Biopharmaceuticals was founded in 2006.

Where is 3P Biopharmaceuticals located?

3P Biopharmaceuticals is headquartered in Noain, Spain. It is registered at Noain, Navarra, Spain.

Who is the current CEO of 3P Biopharmaceuticals?

Damaso Molero is the current CEO of 3P Biopharmaceuticals.

What does 3P Biopharmaceuticals do?

Founded in 2006, 3P Biopharmaceuticals operates as a GMP-certified CMO in the biopharmaceutical sector from Noain, Spain. Process development is conducted for prokaryotic and eukaryotic systems, encompassing upstream and downstream processing. Services include expression system generation, process optimization, cell bank creation and characterization, as well as formulation and stability studies for biologics, biosimilars, and cell therapies.

Who are the top competitors of 3P Biopharmaceuticals?

3P Biopharmaceuticals's top competitors include KBI Biopharma, Aldevron and Ovagen.

What products or services does 3P Biopharmaceuticals offer?

3P Biopharmaceuticals offers Proteins Manufacturing, Viral Vectors, Plasmid DNA, Cell Therapies, and 2 more products and services.

Who are 3P Biopharmaceuticals's investors?

3P Biopharmaceuticals has 1 investor. Key investors include Keensight Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available